Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc. (Delaware) is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Actinium Pharmaceuticals Inc. (Delaware) could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Actinium Pharmaceuticals Inc. (Delaware) is not a good value stock. Actinium Pharmaceuticals Inc. (Delaware) is not very popular among insiders. Actinium Pharmaceuticals Inc. (Delaware) is a mediocre stock to choose.

Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing...

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Globe Newswire NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Actinium Pharmaceuticals, Inc...\n more…

Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Actinium Pharmaceuticals, Inc. (Actinium or the Company) (NYSE: ATNM). Investors...\n more…